isabelobrien, Author at European Medical Journal - Page 27 of 68

The world

US funding pause potential threat to global HIV efforts, warns WHO

The World Health Organization has responded to the US government’s freezing of HIV funding as part of a broader pause in foreign aid.

The word spotlight on a blue background

Spotlight: January 2025

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in women’s health.

Charl van Zyl, Lundbeck Pharmaceuticals

Lundbeck’s Charl van Zyl on a new era in neurology

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

GSK and Oxford unite to advance cancer vaccine research

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

male and female symbols

Physicians feel unequipped to address women's health gaps

According to new findings by the HBA and FemTechnology, there are significant systemic challenges and unmet needs in women’s healthcare

The 2025 pharma forecast

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.

Takeda takes lead role in Crohn’s Disease biomarker study

Takeda is serving as the Industry Lead in the newly launched INTERCEPT project – a multinational collaboration to identify predictive biomarkers for Crohn’s Disease.

5 minutes with... Dr Matthew Hickling, Allergan Aesthetics

Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.

Janet Abrahm

Onc Now: Episode 9: The Power of Palliative Care

Janet Abrahm, Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute breaks stigmas around palliative care and supportive oncology.

Gold crown on blue background

The HBA crowns its '2025 Woman of the Year'

The Healthcare Businesswomen’s Association (HBA) has announced its 2025 winners as Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US.